{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T09:39:20Z","timestamp":1795081160471,"version":"4.10.2"},"reference-count":36,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,5]]},"abstract":"<jats:p>\n                    Renal cell carcinoma with (angio) leiomyomatous stroma (RCCLMS) is included as a provisional entity in the 2016 World Health Organization (WHO) classification of renal epithelial neoplasia; however, debate remains whether it represents a distinct entity or a heterogenous group of renal cell carcinomas (RCCs) with overlapping morphology. Also, its relationship to similar tumors occurring in the setting of tuberous sclerosis complex (TSC) is not fully addressed. We analyzed the clinicopathologic, immunohistochemical, and molecular characteristics of 23 sporadic RCCs associated with smooth muscle stroma and classified them into 2 groups, independent of molecular results: (1) RCCLMS (n=18) and (2) clear cell renal cell carcinoma (CCRCC) (n=5). The classification of a case as \u201cRCCLMS\u201d was based on morphologic comparison with 5 \u201cindex\u201d RCCs from 3 patients with TSC showing similar features and the presence of diffuse CK7 expression. To investigate mutational and copy number alterations, a 170-gene solid tumor panel was utilized to sequence 14 RCCLMSs and control of 5 CCRCCs. Also, 4 RCCLMSs, suspicious for chromosome 8 monosomy, were further evaluated by a broader 479 gene sequencing panel that included\n                    <jats:italic toggle=\"yes\">ELOC<\/jats:italic>\n                    (also referred to as\n                    <jats:italic toggle=\"yes\">TCEB1<\/jats:italic>\n                    ). Clinical information and follow-up data were obtained from electronic medical records. The mean age of patients with RCCLMS was 52 years (range, 33 to 69) with male:female ratio of 1:2. Macroscopically, all tumors were solitary and predominantly (82%) tan\/red, circumscribed, and solid. The average tumor size was 2.3\u2009cm (range, 1.1 to 4.5). Microscopically, the distinctive feature included tumor nodules of elongated and frequently branching tubules lined by cells with voluminous clear to mildly eosinophilic cytoplasm (100%), separated by focal to prominent smooth muscle stroma. Additional frequently identified features included: biphasic pattern of collapsed acini surrounding tubules with voluminous cytoplasm (50%), focal papillary architecture (39%), peritumoral lymphoid aggregates (39%), and hemosiderin-laden macrophages (33%). All 11 (100%) RCCLMSs with available staging information were pT1; 78% were WHO\/International Society of Urologic Pathology (ISUP) grade 2 and 22% grade 3. Immunophenotypically, RCCLMSs were characterized by diffuse CK7, CAM5.2 and CD10 reactivity (100%). All patients with available follow-up (n=10) were alive and without disease progression after a mean and median follow-up of 25.2 (range: 1 to 58) and 25 months, respectively. The molecular results showed recurrent mutations in all RCCLMS:\n                    <jats:italic toggle=\"yes\">TSC1<\/jats:italic>\n                    (4),\n                    <jats:italic toggle=\"yes\">TSC2<\/jats:italic>\n                    (4),\n                    <jats:italic toggle=\"yes\">MTOR<\/jats:italic>\n                    (6), and\/or\n                    <jats:italic toggle=\"yes\">ELOC<\/jats:italic>\n                    (2). Five control CCRCCs demonstrated primary alterations in\n                    <jats:italic toggle=\"yes\">VHL<\/jats:italic>\n                    gene, while all 14 RCCLMS cases tested had intact\n                    <jats:italic toggle=\"yes\">VHL<\/jats:italic>\n                    gene. Of 2 RCCLMSs with confirmed monosomy 8, 1 showed a hotspot\n                    <jats:italic toggle=\"yes\">ELOC<\/jats:italic>\n                    mutation without\n                    <jats:italic toggle=\"yes\">TSC\/MTOR<\/jats:italic>\n                    mutations, and 1 showed a previously undescribed 3-bp in-frame\n                    <jats:italic toggle=\"yes\">ELOC<\/jats:italic>\n                    deletion, along with a truncating\n                    <jats:italic toggle=\"yes\">TSC1<\/jats:italic>\n                    mutation. In conclusion, RCCLMS, as defined herein, harbors recurrent mutations of\n                    <jats:italic toggle=\"yes\">TSC1<\/jats:italic>\n                    \/\n                    <jats:italic toggle=\"yes\">TSC2<\/jats:italic>\n                    ,\n                    <jats:italic toggle=\"yes\">MTOR<\/jats:italic>\n                    , and\/or\n                    <jats:italic toggle=\"yes\">ELOC<\/jats:italic>\n                    , consistent with hyperactive\n                    <jats:italic toggle=\"yes\">MTOR<\/jats:italic>\n                    complex. Our findings argue that these tumors represent the sporadic counterpart to morphologically identical tumors occurring in TSC patients. Finally, the data support that RCCLMS is a novel subtype of RCC with unique morphologic, immunohistochemical, and molecular characteristics that is distinct from CCRCC and clear cell-papillary RCC.\n                  <\/jats:p>","DOI":"10.1097\/pas.0000000000001422","type":"journal-article","created":{"date-parts":[[2019,12,17]],"date-time":"2019-12-17T09:01:22Z","timestamp":1576573282000},"page":"571-581","source":"Crossref","is-referenced-by-count":117,"title":["\u201cRenal Cell Carcinoma With Leiomyomatous Stroma\u201d Harbor Somatic Mutations of TSC1, TSC2, MTOR, and\/or ELOC (TCEB1): Clinicopathologic and Molecular Characterization of 18 Sporadic Tumors Supports a Distinct Entity"],"prefix":"10.1097","volume":"44","author":[{"given":"Rajal B.","family":"Shah","sequence":"first","affiliation":[{"name":"Robert J. Tomsich Pathology and Laboratory Medicine Institute, The Cleveland Clinic, Cleveland, OH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradley A.","family":"Stohr","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of California, San Francisco, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng Jin","family":"Tu","sequence":"additional","affiliation":[{"name":"Robert J. Tomsich Pathology and Laboratory Medicine Institute, The Cleveland Clinic, Cleveland, OH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Gao","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, University of Calgary, Calgary, AB, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher G.","family":"Przybycin","sequence":"additional","affiliation":[{"name":"Robert J. Tomsich Pathology and Laboratory Medicine Institute, The Cleveland Clinic, Cleveland, OH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane","family":"Nguyen","sequence":"additional","affiliation":[{"name":"Robert J. Tomsich Pathology and Laboratory Medicine Institute, The Cleveland Clinic, Cleveland, OH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roni M.","family":"Cox","sequence":"additional","affiliation":[{"name":"Robert J. Tomsich Pathology and Laboratory Medicine Institute, The Cleveland Clinic, Cleveland, OH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fariborz","family":"Rashid-Kolvear","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, University of Calgary, Calgary, AB, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael D.","family":"Weindel","sequence":"additional","affiliation":[{"name":"Robert J. Tomsich Pathology and Laboratory Medicine Institute, The Cleveland Clinic, Cleveland, OH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel H.","family":"Farkas","sequence":"additional","affiliation":[{"name":"Robert J. Tomsich Pathology and Laboratory Medicine Institute, The Cleveland Clinic, Cleveland, OH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiril","family":"Trpkov","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, University of Calgary, Calgary, AB, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesse K.","family":"McKenney","sequence":"additional","affiliation":[{"name":"Robert J. Tomsich Pathology and Laboratory Medicine Institute, The Cleveland Clinic, Cleveland, OH"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2019,12,16]]},"reference":[{"key":"R2-20230922","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/S0344-0338(11)81110-6","article-title":"Mixed renal tumor with carcinomatous and fibroleiomyomatous components, associated with angiomyolipoma in the same kidney","volume":"189","author":"Canzonieri","year":"1993","journal-title":"Pathol Res Pract"},{"key":"R3-20230922","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1097\/01.pas.0000213277.45715.82","article-title":"Renal cell carcinoma associated with prominent angioleiomyoma-like proliferation: report of 5 cases and review of the literature","volume":"30","author":"Kuhn","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"R4-20230922","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1038\/modpathol.2013.180","article-title":"Renal cell carcinoma with smooth muscle stroma lacks chromosome 3p and VHL alterations","volume":"27","author":"Martignoni","year":"2014","journal-title":"Mod Pathol"},{"key":"R5-20230922","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1111\/his.12040","article-title":"Renal cell carcinoma with clear cells, smooth muscle stroma, and negative for 3p deletion: a variant of renal angiomyoadenomatous tumour? A case report","volume":"62","author":"Iczkowski","year":"2013","journal-title":"Histopathology"},{"key":"R6-20230922","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.humpath.2008.05.021","article-title":"Clear cell renal cell carcinoma with smooth muscle stroma","volume":"40","author":"Shannon","year":"2009","journal-title":"Hum Pathol"},{"key":"R7-20230922","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1053\/adpa.2000.17890","article-title":"Benign renal angiomyoadenomatous tumor: a previously unreported renal tumor","volume":"4","author":"Michal","year":"2000","journal-title":"Ann Diagn Pathol"},{"key":"R8-20230922","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1007\/s00428-009-0788-9","article-title":"Difference between RAT and clear cell papillary renal cell carcinoma\/clear renal cell carcinoma","volume":"454","author":"Michal","year":"2009","journal-title":"Virchows Arch"},{"key":"R9-20230922","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s00428-008-0697-3","article-title":"Renal angiomyoadenomatous tumor: morphologic, immunohistochemical, and molecular genetic study of a distinct entity","volume":"454","author":"Michal","year":"2009","journal-title":"Virchows Arch"},{"key":"R10-20230922","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/01.pas.0000185382.80844.b1","article-title":"Spectrum of epithelial neoplasms in end-stage renal disease: an experience from 66 tumor-bearing kidneys with emphasis on histologic patterns distinct from those in sporadic adult renal neoplasia","volume":"30","author":"Tickoo","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"R11-20230922","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1097\/PAS.0b013e318164bcbb","article-title":"Clear cell papillary renal cell carcinoma: a distinct histopathologic and molecular genetic entity","volume":"32","author":"Gobbo","year":"2008","journal-title":"Am J Surg Pathol"},{"key":"R12-20230922","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.humpath.2013.08.004","article-title":"Clear cell papillary renal cell carcinoma is the fourth most common histologic type of renal cell carcinoma in 290 consecutive nephrectomies for renal cell carcinoma","volume":"45","author":"Zhou","year":"2014","journal-title":"Hum Pathol"},{"key":"R13-20230922","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1097\/PAS.0000000000000446","article-title":"Clear cell-papillary renal cell carcinoma of the kidney not associated with end-stage renal disease: clinicopathologic correlation with expanded immunophenotypic and molecular characterization of a large cohort with emphasis on relationship with renal angiomyoadenomatous tumor","volume":"39","author":"Aron","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"R14-20230922","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1097\/PAS.0000000000000456","article-title":"Clear cell papillary renal cell carcinoma and renal angiomyoadenomatous tumor: two variants of a morphologic, immunohistochemical, and genetic distinct entity of renal cell carcinoma","volume":"39","author":"Deml","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"R15-20230922","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.anndiagpath.2015.11.003","article-title":"Clear cell papillary renal cell carcinoma, renal angiomyoadenomatous tumor, and renal cell carcinoma with leiomyomatous stroma relationship of 3 types of renal tumors: a review","volume":"21","author":"Hes","year":"2016","journal-title":"Ann Diagn Pathol"},{"key":"R16-20230922","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1097\/PAS.0000000000000248","article-title":"Tuberous sclerosis-associated renal cell carcinoma: a clinicopathologic study of 57 separate carcinomas in 18 patients","volume":"38","author":"Guo","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"R17-20230922","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1097\/PAS.0000000000000237","article-title":"Renal cell carcinoma in tuberous sclerosis complex","volume":"38","author":"Yang","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"R18-20230922","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/modpathol.2015.6","article-title":"TCEB1-mutated renal cell carcinoma: a distinct genomic and morphological subtype","volume":"28","author":"Hakimi","year":"2015","journal-title":"Mod Pathol"},{"key":"R19-20230922","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1038\/modpathol.2017.72","article-title":"Renal cell tumors with clear cell histology and intact VHL and chromosome 3p: a histological review of tumors from the Cancer Genome Atlas database","volume":"30","author":"Favazza","year":"2017","journal-title":"Mod Pathol"},{"key":"R20-20230922","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s00428-016-1952-7","article-title":"Unclassified renal cell carcinoma with tubulopapillary architecture, clear cell phenotype, and chromosome 8 monosomy: a new kid on the block","volume":"469","author":"Lan","year":"2016","journal-title":"Virchows Arch"},{"key":"R21-20230922","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.anndiagpath.2014.08.004","article-title":"Renal cell carcinoma with leiomyomatous stroma--further immunohistochemical and molecular genetic characteristics of unusual entity","volume":"18","author":"Peckova","year":"2014","journal-title":"Ann Diagn Pathol"},{"key":"R22-20230922","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/his.13727","article-title":"New and emerging renal entities: a perspective post-WHO 2016 classification","volume":"74","author":"Trpkov","year":"2019","journal-title":"Histopathology"},{"key":"R23-20230922","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1097\/PAS.0b013e318299f0fb","article-title":"The International Society of Urological Pathology (ISUP) grading system for renal cell carcinoma and other prognostic parameters","volume":"37","author":"Delahunt","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"R25-20230922","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/path.5243","article-title":"Genomic profiling of combined hepatocellular-cholangiocarcinoma reveals similar genetics to hepatocellular carcinoma","volume":"248","author":"Joseph","year":"2019","journal-title":"J Pathol"},{"key":"R26-20230922","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1038\/modpathol.2011.80","article-title":"Clear-cell papillary renal cell carcinoma: molecular and immunohistochemical analysis with emphasis on the von Hippel-Lindau gene and hypoxia-inducible factor pathway-related proteins","volume":"24","author":"Rohan","year":"2011","journal-title":"Mod Pathol"},{"key":"R27-20230922","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.humpath.2017.11.013","article-title":"Renal cell carcinoma with angioleiomyoma-like stroma and clear cell papillary renal cell carcinoma: exploring SDHB protein immunohistochemistry and the relationship to tuberous sclerosis complex","volume":"75","author":"Williamson","year":"2018","journal-title":"Hum Pathol"},{"key":"R28-20230922","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1097\/PAS.0000000000001170","article-title":"Somatic mutations of TSC2 or MTOR characterize a morphologically distinct subset of sporadic renal cell carcinoma with eosinophilic and vacuolated cytoplasm","volume":"43","author":"Chen","year":"2019","journal-title":"Am J Surg Pathol"},{"key":"R29-20230922","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1097\/PAS.0000000000001255","article-title":"Genetic underpinnings of renal cell carcinoma with leiomyomatous stroma","volume":"43","author":"Parilla","year":"2019","journal-title":"Am J Surg Pathol"},{"key":"R30-20230922","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1111\/his.13791","article-title":"Reactivity of CK7 across the spectrum of renal cell carcinomas with clear cells","volume":"74","author":"Gonzalez","year":"2019","journal-title":"Histopathology"},{"key":"R31-20230922","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1097\/PAS.0000000000000514","article-title":"Clear cell renal cell carcinoma with borderline features of clear cell papillary renal cell carcinoma: combined morphologic, immunohistochemical, and cytogenetic analysis","volume":"39","author":"Williamson","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"R32-20230922","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s00428-014-1591-9","article-title":"The leiomyomatous stroma in renal cell carcinomas is polyclonal and not part of the neoplastic process","volume":"465","author":"Petersson","year":"2014","journal-title":"Virchows Arch"},{"key":"R33-20230922","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.eururo.2018.06.007","article-title":"Somatic bi-allelic loss of TSC genes in eosinophilic solid and cystic renal cell carcinoma","volume":"74","author":"Mehra","year":"2018","journal-title":"Eur Urol"},{"key":"R34-20230922","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1097\/PAS.0000000000001067","article-title":"Are sporadic eosinophilic solid and cystic renal cell carcinomas characterized by somatic tuberous sclerosis gene mutations?","volume":"42","author":"Parilla","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"R35-20230922","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1097\/PAS.0000000000000838","article-title":"Eosinophilic solid and cystic renal cell carcinoma (ESC RCC): further morphologic and molecular characterization of ESC RCC as a distinct entity","volume":"41","author":"Trpkov","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"R36-20230922","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1097\/PAS.0000000000000508","article-title":"Eosinophilic, solid, and cystic renal cell carcinoma: clinicopathologic study of 16 unique, sporadic neoplasms occurring in women","volume":"40","author":"Trpkov","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"R37-20230922","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1007\/s00428-018-2456-4","article-title":"\u201cHigh-grade oncocytic renal tumor\u201d: morphologic, immunohistochemical, and molecular genetic study of 14 cases","volume":"473","author":"He","year":"2018","journal-title":"Virchows Arch"},{"key":"R38-20230922","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1111\/his.13876","article-title":"High-grade oncocytic tumour (HOT) of kidney in a patient with tuberous sclerosis complex","volume":"75","author":"Trpkov","year":"2019","journal-title":"Histopathology"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000001422","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,22]],"date-time":"2023-09-22T18:52:04Z","timestamp":1695408724000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000001422"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,16]]},"references-count":36,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000001422","relation":{},"ISSN":["0147-5185"],"issn-type":[{"value":"0147-5185","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12,16]]}}}